Why did Oncternal Therapeutics, Inc. (ONCT) shares plunge in the post-hours trading?
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) stock dipped -24.6% to $4.75 in the after-hours session last-night as a biotech giant confirmed that owing to interest, the